In: Infos about PAASP
EQIPD: PAASP’s contribution to the new Quality System for preclinical research
October 8, 2020EQIPD (European Quality In Preclinical Data) is a project that was funded by the Innovative Medicine Initiative with the vision to enable a…
Read MorePEERS – the Platform for the Exchange of Experimental Research Standards
October 8, 2020We are happy to announce that PAASP is part of the PEERS (Platform for the Exchange of Experimental Research Standards) initiative, which is supported by…
Read MoreResearch rigor in preclinical studies on biological effects of whole-body exposure to electromagnetic fields (2G/3G cell phone technology)
May 26, 2020Various modern technologies are known to bear risks to the human health. In many cases, the society learns about these risks…
Read MoreData analysis – Issues, challenges and solutions
March 31, 2020The first official meeting of the Preclinical Data Forum took place in Berlin in 2014 and one of the central seminars was given…
Read MoreNew Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology
February 1, 2020To improve the robustness and transparency of scientific reporting, the American Society for Pharmacology and Experimental Therapeutics (ASPET), with input from PAASP’s Martin…
Read MorePAASP US, LLC receives funding from NIH
January 29, 2020The PAASP Network is very glad to announce that the NIH has awarded an SBIR grant to a Network member –…
Read MorePAASP at the REWARD/EQUATOR Conference in Berlin (February 20-22, 2020)
December 18, 2019We will present our activities to improve Good Research Practice and Data Quality and are very much looking forward to meet…
Read MorePAASP signed the DORA Declaration
December 11, 2019The Declaration on Research Assessment (DORA) recognizes the need to improve the ways in which the outputs of scholarly research are…
Read MoreNews from NIDA
November 22, 2019The National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), is pleased to announce an…
Read MorePresentation of the newly developed Guidelines On Target Validation for Innovative Therapeutics (GOT-IT)
November 22, 2019Representing the GOT-IT Team, Christoph Emmerich presented the GOT-IT Guidelines at the “BMBF Vernetzungstreffen zur Nationalen Wirkstoffinitiative” on the 8th of October…
Read More